The factor structure of the Mystical Experience Questionnaire (MEQ): Reply to Barrett & Griffiths (2016) Read More > January 25, 2017
Reply to: Ketamine and Psychosis History: Antidepressant Efficacy and Psychotomimetic Effects Postinfusion Read More > January 23, 2017
The fibrinolytic system: A new target for treatment of depression with psychedelics Read More > January 23, 2017
Tackling Harm Reduction, Human Rights and Drug Uses on Recreational Environments: Tensions, Potentialities and Learnings from the Kosmicare Project (Portugal) Read More > January 16, 2017
Weak phantasy and visionary phantasy: the phenomenological significance of altered states of consciousness Read More > January 3, 2017
Ketamine for the treatment of major depressive disorder and bipolar depression: A review of the literature Read More > January 1, 2017
Ayahuasca: An ancient sacrament for treatment of contemporary psychiatric illness? Read More > January 1, 2017
Clinical potential of psilocybin as a treatment for mental health conditions Read More > January 1, 2017
